{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-283662","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2023-11-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.855146+00:00","generated_at":"2026-06-07T21:09:37.552293+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Cytek Biosciences posts updated corporate presentation, no material new info disclosed","bullets":["Filing references updated corporate presentation made available on company website.","Presentation slide lists CEO Dr. Wenbin Jiang, CFO Patrik Jeanmonod, and IR Paul Goodson.","No specific financial figures, guidance changes, or operational updates are provided in the filing or exhibit.","The 8-K furnishes the presentation under Regulation FD; content not incorporated by reference."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-283662","json":"https://secwatch.observer/filing/0001193125-23-283662.json","markdown":"https://secwatch.observer/filing/0001193125-23-283662.md","text":"https://secwatch.observer/filing/0001193125-23-283662.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312523283662/0001193125-23-283662-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312523283662/d614953d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T21:09:37.552293+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}